This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Next Generation CAR & T Cell Therapies

LAST CHANCE: REGISTER BY MAY 20 TO SAVE UP TO $300

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
June 14-16, 2022
Delivered as a Hybrid EventIntercontinental Mark Hopkins Hotel, San Francisco, California

June 14-16, 2022
Delivered as a Hybrid Event,
Intercontinental Mark Hopkins Hotel, San Francisco, California

CAR AND T CELL THERAPIES: IMPROVE THE SAFETY & EFFICACY OF YOUR NOVEL CAR MODALITIES THROUGH TRANSLATIONAL SCIENCE AND CUTTING EDGE CLINICAL DATA

Revolutionizing cell and gene engineering - ground breaking autologous and allogeneic treatments for blood borne and solid tumors

Novel Technological Advances & Applications to help you Revolutionize Early Phase Development

Below are the key topics to be covered during this years event.

Making CAR-T Therapy Safer

Considering the side effects that CAR-T Therapy may have on patients, CAR-T developers are developing next-generation CAR T-cells that are safer for patients.

Attend our event to learn more about the making CAR-T Therapy safer and more effective.

The Next Frontier of CAR T-Cell Therapy: Solid Tumors

Scientists are now hoping to apply CAR-T therapy to treat solid tumors. Both types of cancer present challenges.

Learn more about the application of CAR T-Cell therapies for solid tumours from the cell and gene therapy experts by attending our event!

Off the Shelf CART T-Cells

One big goal in the CAR-T field is the development of an allogeneic CAR-T therapy. The technology would save precious time to patients, which currently have to wait for about two weeks while their cells are shipped to the manufacturing facilities, engineered, and returned.

Attend our event to learn about the progression of Off the Shelf CART T-Cell research and findings. 

PRESENT A SCIENTIFIC POSTER AT Next Generation CAR & T Cell Therapies 2022

Any registered conference pass holder is eligible to present a scientific poster at no additional charge.   Poster space is limited so be sure to register your pass today and submit your poster abstract at the link below.  The deadline to submit a poster abstract is May 13, 2022 and is subject to space availability.  All posters will also be available to view in a Digital Format for our Digital Experience Attendees.


CONNECT WITH KEY BUYERS AT NEXT GENERATION CAR & T CELL THERAPIES 2022

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

Contact Perri Lucatello: PLucatello@informaconnectls.com | +44 (0)7717 508900